FDA's Draft Track and Trace Guidance Is Too Late As Serialization Systems Are Already In Place - Industry
The pharmaceutical industry sees many problems with US FDA’s draft guidance on product serialization to comply with the Drug Supply Chain Security Act of 2012, including requirements for “absolute uniformity.” Moreover, it’s coming out too late for companies that long ago set up serialization IT systems to comply with a November deadline.
You may also be interested in...
US FDA Commissioner Scott Gottlieb says Congress intended to preempt all state licensure laws that were not identical to federal laws for licensing wholesalers and third-party logistics providers under the Drug Supply Chain Security Act.
Drug manufacturers, wholesale distributors and pharmacies urge FDA to issue guidance ahead of the agency’s November deadline on exchanging information about a drug as it moves through the supply chain.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.